This company develops advanced microfluidic and milli-fluidic platforms for biotechnology applications. Their technology integrates surface plasmon resonance and rapid prototyping for high-throughput analysis. The systems support research in areas like bacteriophage susceptibility testing and organ-in-chip models for personalized medicine.
Funding
Funding not disclosed
Founders
Product
Problem
Biotechnology research and development often requires precise control of small volumes of liquids, but traditional methods lack the accuracy and efficiency needed for advanced experiments. Existing equipment can be bulky, expensive, and difficult to integrate into existing workflows, hindering innovation.
Solution
This startup designs and manufactures microfluidic systems that enable precise fluid manipulation at the microscale, addressing the limitations of traditional methods in biotechnology R&D. Their technology facilitates experiments requiring accurate control of small liquid volumes, providing researchers with the tools needed to advance biotechnological innovations. By offering innovative solutions for microfluidic technology, the company empowers scientists to conduct experiments with greater precision and efficiency.
Target Audience
The primary customers are biotechnology researchers and development teams requiring precise control of small liquid volumes for their experiments.
Features
- Microfluidic systems designed for biotechnology research and development
- Precise fluid manipulation at the microscale